Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Short term Debt (2016)

Historic Short term Debt for Gyre Therapeutics (GYRE) over the last 8 years, with Q3 2016 value amounting to $28000.0.

  • Gyre Therapeutics' Short term Debt fell 9585.8% to $28000.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $28000.0, marking a year-over-year decrease of 9585.8%. This contributed to the annual value of $1.2 million for FY2015, which is N/A changed from last year.
  • Latest data reveals that Gyre Therapeutics reported Short term Debt of $28000.0 as of Q3 2016, which was down 9585.8% from $130000.0 recorded in Q2 2016.
  • Gyre Therapeutics' 5-year Short term Debt high stood at $1.2 million for Q4 2015, and its period low was $28000.0 during Q3 2016.
  • For the 5-year period, Gyre Therapeutics' Short term Debt averaged around $690625.0, with its median value being $847500.0 (2012).
  • Its Short term Debt has fluctuated over the past 5 years, first skyrocketed by 4142.26% in 2015, then crashed by 9585.8% in 2016.
  • Quarter analysis of 5 years shows Gyre Therapeutics' Short term Debt stood at $851000.0 in 2012, then increased by 0.24% to $853000.0 in 2013, then tumbled by 43.96% to $478000.0 in 2014, then soared by 141.84% to $1.2 million in 2015, then plummeted by 97.58% to $28000.0 in 2016.
  • Its Short term Debt stands at $28000.0 for Q3 2016, versus $130000.0 for Q2 2016 and $196000.0 for Q1 2016.